Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC ANTI-HER2 PERTUZUMAB-5mg
SDP

Catalog No. 5000897593
Encompass_Preferred

Anti-ERBB2/HER2/CD340 Antibody (Pertuzumab) (CAS No 380610-27-5) is a monoclonal antibody used in cancer research particularly for targeting the ERBB2/HER2 receptor pathway which is overexpressed in certain breast cancers It functions by binding to HER2 and inhibiting dimerization preventing downstream signaling necessary for tumor growth This antibody exhibits in vitro activity in the nanomolar range effectively disrupting cell proliferation in HER2-positive cell lines Common applications include studies in cell models and animal studies to assess antitumor efficacy and it is frequently used in drug screening platforms Experimental concentrations typically depend on the specific research design

Catalog No. 50-008-97593 Supplier Apexbio Technology LLC Supplier No. F14075
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Anti-ERBB2/HER2/CD340 Antibody (Pertuzumab) (CAS No 380610-27-5) is a monoclonal antibody used in cancer research particularly for targeting the ERBB2/HER2 receptor pathway which is overexpressed in certain breast cancers It functions by binding to HER2 and inhibiting dimerization preventing downstream signaling necessary for tumor growth This antibody exhibits in vitro activity in the nanomolar range effectively disrupting cell proliferation in HER2-positive cell lines Common applications include studies in cell models and animal studies to assess antitumor efficacy and it is frequently used in drug screening platforms Experimental concentrations typically depend on the specific research design

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.